Sunday, December 8, 2002 - including Plenary Sessions

ASH 2002

OncoLink attended the 44th Annual Meeting of the American Society of Hematology (ASH) from Philadelphia, Pennsylvania. OncoLink reporters provided in-depth, up-to-the-minute coverage of sessions and presentations.

ASH Attendees
ASH Attendees at the Pennsylvania Convention Center

Characterization of the Genomic Breakpoint in t(11:18)(q21:q21) of MALT Lymphoma Double Autologous Transplantation Improves Survival of Multiple Myeloma Patients: Final Analysis of a Prospective Randomized Study of the "Intergroupe Francophone du Myelome" (IFM-94). High Incidence of t(11:18)(q21:q21) in Helicobacter pylori Negative Gastric MALT Lymphoma Histological and Clinical Prognostic Factors in Follicular Lymphoma: Proposal for a Prognostic Model Imatinib (STI571, Gleevac) as Initial Therapy for Patients with Newly Diagnosed Ph + Chronic Myeloid Leukemia (CML): Results of a Randomized Phase III Study vs Interferon-Alpha + Cytarabine (IFN + AraC) Isolated Central Nervous System (ICNS) Relapse in Children With Standard Risk (SR) ALL: Results of CCG-1952. Long term follow up of an Alemtuzumab (CAMPATH-1H) containing reduced intensity Allogeneic Transplant Regimen for Non-Hodgkins Lymphoma (NHL) Peptide Vaccination with PR1 Elicits Active T Cell Immunity That Induces Cytogenetic Remission in Acute Myelogenous Leukemia. Primary Pulmonary MALT Lymphomas Show Frequent and Heterogenous Cytogenetic Abnormalities, Including a Previously Unreported MALT1-IGH Translocation Results of Myeloablative Allogenic Stem Cell Transplant (SCT) for Severe Sickle Cell Disease in France Separation of Blood and Lymphatic Vascular Networks Is Regulated by the Hematopoietic Signaling Proteins SLP-76 and Syk. Thioguanine-Related Veno-Occlusive Disease (VOD) of the Liver in Children with Acute Lymphoblastic Leukemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) Trial ALL97


Click on any of these terms for more related articles